Astarte Medical Partners, Inc. develops a software that provides a universal view of clinical data in real time to assess the state of the preterm infant’s gut health to make more informed decisions. The product enables NICU clinical care teams to standardize and streamline the practice of feeding. Astarte Medical Partners, Inc. was incorporated in 2016 and is based in Yardley, Pennsylvania.
RecoveryLink provides a comprehensive software-as-a-service digital recovery support platform aimed at enhancing behavioral health outcomes. Its offerings include electronic recovery records, asynchronous digital training, and both one-on-one telerecovery peer services and live video group-based recovery support. By integrating these tools, RecoveryLink enables clients to access a range of effective recovery support resources, facilitating a transformation in the delivery of behavioral health services. The platform is designed to maximize organizational effectiveness while ensuring that individuals receive the necessary support for their recovery journeys.
Repisodic, Inc. is a healthcare technology company based in Philadelphia, Pennsylvania, focused on improving the transition of patients from hospitals to post-acute care settings, such as nursing homes and rehabilitation centers. Founded in 2017, Repisodic offers solutions that enhance care decision-making for patients, families, and caregivers. Its flagship products include Repisodic Choice, which helps hospitals and health systems create dynamic preferred provider networks tailored to individual patient needs, and Repisodic Link, designed for post-acute care providers to facilitate referrals and connect with patients. The platform utilizes proprietary data and automation to streamline the discharge process, allowing discharge planners to match patients with suitable post-discharge options based on factors like insurance networks and clinical capabilities. Overall, Repisodic aims to revolutionize how care decisions are made, ensuring that patients receive optimal post-hospital care.
MediScore Health is a healthcare technology company that specializes in providing data insights and solutions for chronic care management and risk adjustment, specifically targeting Medicare Advantage payers and Accountable Care Organizations (ACOs). Founded in 2017 and headquartered in Philadelphia, Pennsylvania, with an additional office in Santa Monica, California, the company offers a comprehensive online platform. This platform includes physician-driven chart review and analytics, predictive diagnostics, and point-of-care disease management services. By equipping healthcare providers with tools to efficiently diagnose, document, and manage chronically ill patients, MediScore Health aims to enhance patient outcomes and streamline care delivery at the primary care level.
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.
Hava Health, Inc. is a health company based in the United States that focuses on developing solutions for smoking cessation. The company manufactures a connected vape pen designed for individuals struggling with nicotine addiction. This device pairs with a smartphone application called Hale, which supports users in their efforts to quit smoking. Hava Health aims to address the health challenges associated with smoking by offering innovative products that facilitate the cessation process and ultimately reduce smoking-related illnesses and deaths. Currently, the company is in the pre-clinical stage of its development.
Tridiuum, Inc. develops and operates software-as-a-service platform to support behavioral health providers, patients, and health systems across the continuum of care. It offers Tridiuum1, a cloud-based behavioral health outcomes management platform that provides results for monitoring a patient’s symptoms and progress during treatment; and helps health systems and primary care medical groups improve patient experience and outcomes. The company was founded in 1997 and is based in Philadelphia, Pennsylvania.
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
Astarte Medical Partners, Inc. develops a software that provides a universal view of clinical data in real time to assess the state of the preterm infant’s gut health to make more informed decisions. The product enables NICU clinical care teams to standardize and streamline the practice of feeding. Astarte Medical Partners, Inc. was incorporated in 2016 and is based in Yardley, Pennsylvania.
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network. VitalTrax offers Wing, a solution that simplifies clinical trials enrollment. Wing is a clinical trial network that provides innovative ways for people to easily seek optional treatments for themselves or people that they love and play an important role in helping develop new ways to fight diseases.
Shock Analytics LLC is an early-stage biomedical device company based in Philadelphia, Pennsylvania, founded in 2016. The firm specializes in designing and manufacturing noninvasive devices that estimate Systemic Vascular Resistance (SVR), a critical indicator for conditions such as congestive heart failure and sepsis. By utilizing hemodynamic information, Shock Analytics aims to provide medical professionals with innovative tools to improve the treatment and management of critically and chronically ill patients. Through its focus on smarter technologies, the company seeks to transform the landscape of biomedical diagnostics and enhance patient care.
POLARIS HEALTH DIRECTIONS develops and markets behavioral health outcomes assessment and management systems to help deliver better health outcomes at a reduced cost. Polaris systems are designed for use by health care providers, managed care organizations, government agencies and pharmaceutical companies, and focus on addressing the impact mental health conditions have on physical health and an individual’s welfare. These solutions help Polaris's clients identify, monitor and address psychosocial and behavioral health conditions to curb long-term health effects and costs.
GSI Health, LLC is a health information technology company that specializes in population health management through its cloud-based software solutions. Founded in 2003 and headquartered in Philadelphia, Pennsylvania, with an additional office in New York, the company provides tools for care coordination, care management, and health insights. GSI Health's platform is designed to enhance communication and information sharing among healthcare providers, including hospitals, health systems, managed care organizations, Medicaid programs, and community-based organizations. The solutions aim to improve transitions in care, reduce avoidable hospital readmissions, and support analytics and reporting for patient care. Additionally, the platform includes built-in Health Information Exchange (HIE) capabilities, facilitating seamless data sharing across organizational boundaries. As of October 2019, GSI Health operates as a subsidiary of Medecision, Inc.
Instadiagnostics Inc. develops a point-of-care (POC) diagnostic platform with the aim of bringing centralized laboratory testing to the patient’s bedside. The platform allows early diagnosis, and/or treatment monitoring of patients at the POC (primary care centers, community clinics, emergency departments etc.) without requiring additional trips to have blood drawn, lengthy wait times for results or having to wait for diagnosis/follow up testing. Instadiagnostics Inc. was incorporated in 2015 and is based in Philadelphia, Pennsylvania.
Animotion is affordable mobile technology for joint care. Our data facilitates more accurate diagnoses, individualized motivation for at-home treatment, and monitored assessment of effectiveness to reduce readmissions and improve quality of care. Animotion links to web and mobile software applications for real-time instant access.
Instadiagnostics Inc. develops a point-of-care (POC) diagnostic platform with the aim of bringing centralized laboratory testing to the patient’s bedside. The platform allows early diagnosis, and/or treatment monitoring of patients at the POC (primary care centers, community clinics, emergency departments etc.) without requiring additional trips to have blood drawn, lengthy wait times for results or having to wait for diagnosis/follow up testing. Instadiagnostics Inc. was incorporated in 2015 and is based in Philadelphia, Pennsylvania.
DecNut LLC specializes in developing point-of-care technologies aimed at enhancing clinical decision-making across various healthcare environments. The company offers an application that integrates evidence-based clinical practice guidelines directly into healthcare providers' workflows. This integration facilitates improved resource utilization and allows healthcare professionals to efficiently aggregate, update, disseminate, and evaluate customized clinical decision support tools. By focusing on these solutions, DecNut aims to streamline the decision-making process for clinicians, ultimately improving patient outcomes in diverse settings.
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
Grand Round Table Inc. is a developer of clinical decision support tools aimed at enhancing diagnostic accuracy for healthcare providers. The company's flagship system, Grand Round Table, integrates with electronic health records to assist doctors in diagnosing patients by comparing their cases against a comprehensive database of deidentified health records, case reports, and evidence-based medical literature, including resources from the University of Pennsylvania. This technology enables physicians to access insights from previous cases, facilitating quicker and more informed treatment decisions for complex patients. By streamlining the decision-making process, Grand Round Table helps hospitals and clinics reduce unnecessary tests, ineffective treatments, and consultations, ultimately saving time and costs in patient care. Established in 2011, the company is headquartered in Philadelphia, Pennsylvania.
Healthy Reimbursement for Engaging with your Patients on their journey to Better Health, Disease Prevention, and Lifestyle Modification. Ideal Patient/Physician Engagement, Communication, and Ongoing Connectivity help Patients Realize their Goals.
TowerView helps the 1 in 3 Americans with a chronic illness manage multiple medications. TowerView’s patients receive pre-filled medication trays that fit into a connected pillbox like a K-Cup into a Keurig coffee machine. Their pillbox can sense when patients forget a dose and automatically sends a text or phone reminder. Unlike other smart pillboxes, they send patients pre-filled medication trays sourced from a pharmacy so patients never have to fill their own pillbox and they work directly with nurses to target outreach for non-adherent patients. TowerView is rolling out with Independence Blue Cross in January 2015 and are in advanced discussions with numerous other health plans.
Opertech Bio has developed a revolutionary approach to taste testing, a multi-billion market covering the food and beverage, flavor ingredients, pet food, and pharmaceutical industries.
Infarct Reduction Technologies
Seed Round in 2014
Infarct Reduction Technologies develops a therapeutic device for ischemic pre-conditioning protocol. The company offers LifeCuff, a non-invasive manually-inflated blood pressure cuff for remote ischemic conditioning in heart attack, stroke, sepsis, liver surgery, traumatic brain injury, and other critical condition patients. The company is headquartered in Waldwick, New Jersey.
Vy Corporation is a software development company based in Wayne, Pennsylvania, specializing in shape detection and object analysis for the medical imaging market. The company offers cloud-based services, including CytoSavvy.com, which utilizes patented technology to identify and analyze clusters of cells in various biopsies, enhancing the capabilities of pathologists and medical researchers. Another product, VectorSavvy.com, provides users with access to advanced image analysis tools, enabling them to upload and evaluate images effectively. Vy Corporation's mission is to improve the efficiency and reliability of data collection and analysis in medical diagnostics, ultimately aiding in the identification of complex cell structures. Through its innovative software solutions, Vy aims to streamline the process of analyzing medical imagery, thereby supporting better research outcomes in the healthcare sector.
CRO Analytics, LLC specializes in data assessment tools and services for sponsors and contract research organizations. Based in New Hope, Pennsylvania, the company was established in 2011 and offers a cloud-based clinical trial performance system known as Performer. This platform provides a trial assessment system that delivers in-trial alerts, enabling clinical research executives and management teams to enhance research quality, efficiency, and performance management while achieving cost savings. CRO Analytics offers a unique online validated performance data collection system that captures extensive performance assessments from biopharma and service provider personnel involved in outsourced clinical research. The collected data can be analyzed across various dimensions, including service provider, sponsor, region, study type, phase, functional area, and therapeutic area, providing valuable insights into clinical research performance.
HealthQX, founded in 2012 and based in King of Prussia, Pennsylvania, specializes in value-based payment analytic software solutions tailored for health plans and providers. The company's primary offering, ClarityQx, is a comprehensive analytics platform designed to facilitate the design, implementation, and ongoing performance monitoring of various payment models, including episodic, bundled, and accountable care arrangements. This platform provides users with drill-down dashboards that enhance provider engagement and streamline contract negotiation processes. By enabling quick access to critical payment analytics, HealthQX aims to improve consumer care and reduce medical costs within the healthcare industry.
BioDetego is developing, VASPfore, a new biomarker test for selecting cancer treatment protocols. The VASP marker provides information that will direct chemotherapy to high risk patients who will likely benefit from treatment while preventing costly and harmful treatment of low risk patients. BioDetego predicts that the VASPfore will provide payors enormous savings (>$150MM/year) by reducing total treatment costs. The company is led by David Zuzga, Ph.D., Founder and CEO, a research scientist with expertise in cell and molecular biology at La Salle University & Giovanni M. Pitari, M.D., Ph.D. Founder and CSO, a physician and research scientist with expertise in Translational Oncology.
Grand Round Table Inc. is a developer of clinical decision support tools aimed at enhancing diagnostic accuracy for healthcare providers. The company's flagship system, Grand Round Table, integrates with electronic health records to assist doctors in diagnosing patients by comparing their cases against a comprehensive database of deidentified health records, case reports, and evidence-based medical literature, including resources from the University of Pennsylvania. This technology enables physicians to access insights from previous cases, facilitating quicker and more informed treatment decisions for complex patients. By streamlining the decision-making process, Grand Round Table helps hospitals and clinics reduce unnecessary tests, ineffective treatments, and consultations, ultimately saving time and costs in patient care. Established in 2011, the company is headquartered in Philadelphia, Pennsylvania.
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists who would like greater diagnostic confidence in joint fluid analysis. Unlike current technologies, which often yield vague and ambiguous results, CygnaSure™, our lead product, offers orthopaedic surgeons and rheumatologists a rapid, accurate and reliable diagnostic answer.
Real Time Tomography, LLC develops imaging software solutions for medical imaging systems. The company offers Adara, an image processing and enhancement software for digital mammography that provides optimal tissue contrast and lesion conspicuity; and Briona, a 3D image reconstruction software for digital breast tomosynthesis that reconstructs 3D tomographic images from 2D projection images. It also provides technical support and consultation on detector and system design for optimal image quality and processing speed. The company provides its products to the manufacturers of mammography and PACS workstations. Real Time Tomography, LLC was founded in 2006 and is based in Villanova, Pennsylvania.
BioNanomatrix, Inc. develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The company's technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications.